Article info
Commentary
PGAM5: a new player in immune-mediated liver injury
- Correspondence to Dr Hartmut Jaeschke, Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS 66169, USA; hjaeschke{at}kumc.edu
Citation
PGAM5: a new player in immune-mediated liver injury
Publication history
- Received September 18, 2016
- Accepted September 26, 2016
- First published October 19, 2016.
Online issue publication
March 11, 2017
Article Versions
- Previous version (19 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/